Dr. John Talley has been appointed chief scientific officer of SARmont, a provider of medicinal chemistry services. Dr. Talley will oversee all drug design and optimization projects for clients to identify high quality and proprietary investigational new drug (IND) lead candidates. Randy Weiss will serve as SARmont’s first president and chief executive officer. “SARmont partners with pharmaceutical companies, venture capital firms and research institutions to help bring promising new drugs t...